She came in our clinic first in February 2012 for secondary hypomenorrhea lasting for 3 months, hirsutism and worsening of acne. Laboratory examination revealed markedly elevated free testosterone (9.6 nmol/l) and slightly elevated morning cortisol (687.4 nmol/l) with almost no suppression in low dose dexamethasone suppression (1mg) and elevated DHEA-S. 
P R E S E N T A T I O N O F C A S E
yr woman with no concomitant in her history and with negative family history in She was after abortion due to severe congenital anomaly at age 25, and after normal first in February 2012 for secondary hypomenorrhea lasting for 3 months, hirsutism and mination revealed markedly elevated free testosterone (9.6 nmol/l) and slightly elevated morning cortisol (687.4 nmol/l) with almost no suppression test 751 pmol/l 9.6 nmol/l 40.0 3.6 nmol/l 24 nmol/l 1.33 mIU/ml < 1.0 pmol/l Due to testosterone level, CT scan was performed. On CT scan was diagnosed multinodular adrenal tumor 70 x 45mm (60 HU) in right adrenal gland, left adrenal was normal. In lower part of right liver lobe was small hypodense locus 21 x Feochromocytoma was excluded assessment of plasmatic , which was normal, just as chromogranine A level.
T R E A T M E N T
In April 2012 surgery was performed excision of liver tumor and right adrenalectomy, biopsy of liver was benign -cavernous adrenal gland was described feochromocytoma. After hirsutism, acne, level of plasma cortisol, free testosterone and cortisol after suppression For clinical discrepancy (negative metanephrines before surgery, cortisol + testosterone production) second reading of adrenal biopsy and the conclusion was oncocytic variant of adrenal carcinoma partially necrotic, with 6 mitoses per v index 15%, with no lymph-AE 1-3, S100, ACTH, chromogranine, positive for synaptophysine and NSE).
Clinical remission hormonal profile
morning cortisol free testosterone free androgen index DHEAS SHBG TSH ACTH
In June 2012 PET/CT scan was performed, with negative results. Synacthen sufficient cortisol reserve. Patient is now in dispensarization, in conclusion with oncologist no adjuvant treatment was recommended.
D I S C U S S I O N
In comparison with literature, oncocytic adrenocortical carcinoma was firstly described in 2010 in New Zealand and our case is pro of this extremely unique malignancy in the world.
Oncocytic adrenal carcinoma with production of testosterone , Czech Republic
T R E A T M E N T
In April 2012 surgery was performed -open wedge-shaped excision of liver tumor and right adrenalectomy, biopsy of cavernous haemangioma. Biopsy of adrenal gland was described surprisingly in first reading as . After surgery, menstruation cycle, hirsutism, acne, level of plasma cortisol, free testosterone suppression were normalized.
(negative metanephrines before surgery, cortisol + testosterone production) we initiated second reading of adrenal biopsy and the conclusion was variant of adrenal carcinoma (cellular lesion, partially necrotic, with 6 mitoses per visual field, proliferation and angio-invasion, negative for 3, S100, ACTH, chromogranine, positive for Clinical remission hormonal profile 401,8 pmol/l 0.7 nmol/l 1.4 1.5 nmol/l 50.3 nmol/l 2.31 mIU/ml 16.8 pmol/l
In June 2012 PET/CT scan was performed, with complete en test after surgery showed sufficient cortisol reserve. Patient is now in our dispensarization, in conclusion with oncologist no adjuvant treatment was recommended.
D I S C U S S I O N
In comparison with literature, testosterone-secreting adrenocortical carcinoma was firstly described in 2010 in New Zealand and our case is probably the third case of this extremely unique malignancy in the world.
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